A Study to Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients
Clinical trial NCT07409636 · COMPLETED
Trial details
- NCT number
- NCT07409636
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-23
- Primary completion
- 2025-12-22
- Enrollment
- 11991
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.